[Systemic sclerosis]
- PMID: 38366245
- DOI: 10.1007/s00105-024-05298-8
[Systemic sclerosis]
Abstract
Background: Systemic sclerosis (SSc) is a very heterogeneous, chronic, rare, but socioeconomically important disease with a severe disease course and severe impairment of the quality of life of affected patients.
Objectives: Overview of the current state of research on the pathogenesis, diagnosis and therapy of SSc.
Methods: A literature search was performed.
Results: The pathogenesis of SSc is not fully understood. ACR/EULAR criteria allow the diagnosis of early forms of SSc. Classification into limited cutaneous SSc and diffuse cutaneous SSc is of prognostic and therapeutic relevance. New organ-specific treatment options for SSc have led to improved quality of life and prognosis.
Zusammenfassung: HINTERGRUND: Die systemische Sklerose (SSc) stellt eine sehr heterogene, chronische, zwar seltene, jedoch sozioökonomisch bedeutsame Erkrankung mit schwerem Krankheitsverlauf und starker Einschränkung der Lebensqualität betroffener Patienten dar.
Fragestellung: Es wird eine Übersicht zum aktuellen Forschungsstand zu Pathogenese, Diagnostik und Therapie der SSc gegeben.
Material und methode: Es erfolgte eine Literaturrecherche.
Ergebnisse: Die Pathogenese der SSc bleibt bislang weiterhin nicht gänzlich geklärt. ACR(American College of Rheumatology)/EULAR(European League Against Rheumatism)-Kriterien erlauben eine Diagnose auch früher SSc-Formen. Die Klassifikation in limitierte kutane systemische Sklerose (lcSSc) und diffuse kutane systemische Sklerose (dcSSc) ist von prognostischer und therapeutischer Relevanz. Neue organspezifische Therapiemöglichkeiten der SSc haben zu einer verbesserten Lebensqualität und Prognose geführt.
Keywords: Connective tissue hyperplasia; Interdisciplinary health team; Organ-specific treatment; Quality of life; Scleroderma.
© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
Similar articles
-
Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease.J Rheumatol. 2015 Jan;42(1):60-3. doi: 10.3899/jrheum.140047. Epub 2014 Oct 1. J Rheumatol. 2015. PMID: 25274890
-
Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database.Clin Exp Rheumatol. 2018 Jul-Aug;36 Suppl 113(4):68-75. Epub 2018 Sep 29. Clin Exp Rheumatol. 2018. PMID: 30277860
-
The concept of early systemic sclerosis following 2013 ACR\EULAR criteria for the classification of systemic sclerosis.Curr Rheumatol Rev. 2014;10(1):38-44. doi: 10.2174/1573397110666140404001756. Curr Rheumatol Rev. 2014. PMID: 24720644
-
[The road to early diagnosis of systemic sclerosis : the evolution of diagnostic and classification criteria in the past decades].Z Rheumatol. 2013 Dec;72(10):954-9. doi: 10.1007/s00393-013-1194-x. Z Rheumatol. 2013. PMID: 24337197 Review. German.
-
Systemic sclerosis: Recent insight in clinical management.Joint Bone Spine. 2020 Jul;87(4):293-299. doi: 10.1016/j.jbspin.2019.09.015. Epub 2019 Sep 27. Joint Bone Spine. 2020. PMID: 31568838 Review.
References
Literatur
-
- Jerjen R et al (2022) Systemic sclerosis in adults. Part I: clinical features and pathogenesis. J Am Acad Dermatol 87(5):937–954 - PubMed
-
- Arnett FC et al (2001) Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum 44(6):1359–1362 - PubMed
-
- Rosendahl AH, Schonborn K, Krieg T (2022) Pathophysiology of systemic sclerosis (scleroderma). Kaohsiung J Med Sci 38(3):187–195 - PubMed
-
- De Martinis M et al (2016) An overview of environmental risk factors in systemic sclerosis. Expert Rev Clin Immunol 12(4):465–478 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Medical